An exhaustive analysis of the US generic market. The report does a thorough investigation of both the drivers as well as restraints impacting the market, and the factors that distinguish the US from other generic markets of the world.

This 130+ paged report features key figures, including graphs and charts, important tables, news, insights, the latest developments in the parallel trade market with up-to-date analysis.

The US, with its healthcare spending crossing US$ 2.2 Trillion in 2007, represents the most important healthcare product and services market in the world

OTC Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry.

Pharmaceuticals in the United States industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.

Many prescribers rely on websites provided by pharmaceutical companies when searching for treatment information. Consumers also rely heavily on online resources when searching for disease and treatment information. Websites that tailor their site conte

The imminent introduction of Medicare Part D will take place with the US drug market in a transitional period. Negative sentiment towards high prices in the US market has gained currency in recent years, while growth in generics continues to outstrip b

This analysis examines the current position and future outlook for Bristol-Myers Squibb in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with

This analysis examines the current position and future outlook for Roche in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales

This analysis examines the current position and future outlook for Genentech in the biotechnology sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore

This analysis examines the current position and future outlook for Akzo Nobel in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year

The eHealth market in the US is generally more developed than that in Europe. Substantial investment from the government and the pharmaceutical industry has propelled the developments in initiatives such as online continuing medical education. There ap

The value of CME is widely recognized in both the US and Europe. Even so, the approaches these two regions have taken with regard to the regulation, provision and funding of CME activities vary considerably. Therefore, pharmaceutical companies must tak

Healthcare professionals have little time during their work day to search for drug- and disease-related information. Time pressures also limit the amount of time that prescribers are able to spend with sales representatives from pharmaceutical companie

This analysis examines the current position and future outlook for Allergan in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa

Datamonitor has analyzed various US consumer-targeted websites, maintained by the key players within the pharmaceutical industry, with respect to the level of influence these sites have over their target audiences, and the quality of content and servic

This company analysis examines Forest`s current market position and future outlook. The profile encompasses global and US specific company strategy, portfolio and pipeline analysis, and an assessment of financial performance, with sales forecasts for k

This analysis examines the market position and future outlook for Schering AG, encompassing global and US company strategy, portfolio and pipeline analysis and assessment of financial performance, with global, US and ROW forecasts for key drugs to 2010

This analysis examines the current position and future outlook for Millennium in the biotechnology sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales for

This analysis examines the current position and future outlook for Lundbeck in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa

This report examines the actions taken by legislative and regulatory bodies in response to recent drug safety concerns surrounding the COX-2 inhibitors and antidepressants.

This analysis examines the current position and future outlook for Amgen in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales

Analyzes parallel trade market dynamics, reviews the latest regulatory and pricing controls in the EU and US, and assesses the drivers and resistors of parallel trade in 2004.

The pharmaceutical industry is experiencing an increased level of government regulatory intervention. Achieving compliance is of primary concern to every company in the industry. In order to successfully implement eHealth regulations and avoid federal

The eHealth Market in the US analyzes physician and consumer Internet use. It examines the Internet penetration, online information requirements and mobile technology use of both groups. It also looks at trends and physician/consumer attitudes. There a

The US hip and knee replacement markets have undergone a resurgence in growth in the past three years, and it has been more than just an aging population that has driven this growth. This analysis evaluates current market factors and trends, and presen